Amy Schumer Embraces Mounjaro and Hormone Therapy for Improved Health

The comedian shares her positive experience with weight-loss drug Mounjaro and perimenopause treatments after severe side effects from Wegovy.

Amy Schumer reports significant health improvements after starting Mounjaro for weight loss and hormone therapy for perimenopause symptoms.
She previously experienced debilitating nausea and vomiting from Wegovy, which she attributes to a genetic predisposition to nausea.
Schumer has invested in Midi Health, the telehealth company that prescribed her current treatments, citing a positive experience with their care.
She has been outspoken about the importance of transparency in celebrity health discussions, criticizing others for hiding their use of weight-loss drugs.
Mounjaro, primarily designed for Type 2 diabetes, is being used off-label for weight loss, sparking broader conversations about accessibility and insurance coverage.